- ►shouxi.net DJ Angiolillo, A Fernandez-Ortiz, E Bernardo … - Diabetes, 2006 - Am Diabetes Assoc Inhibition of the P2Y 12 pathway by the platelet antagonist clopidogrel is
associated with a marked reduction in platelet reactivity. Recent reports have
shown that P2Y 12 inhibition has anti-inflammatory effects as well. ... Cited by 52 - Related articles - BL Direct - All 6 versions
- ►oxfordjournals.org JP Collet, G Montalescot - European Heart Journal Supplements, 2006 - Eur Soc Cardiology Premature interruption of dual oral antiplatelet therapy is an issue of
increasing importance, and is particularly critical for at least three major
reasons. First, patients eligible for temporary dual oral antiplatelet ... Cited by 12 - Related articles - BL Direct - All 3 versions
PM Ho, ED Peterson, L Wang, DJ Magid, SD … - Jama, 2008 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context It is unknown ... Cited by 71 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org GGL Biondi-Zoccai, M Lotrionte, P Agostoni, A … - European heart journal, 2006 - Eur Soc Cardiology Methods and results Electronic databases were systematically searched (updated
January 2006). Study designs, patient characteristics, and outcomes were
abstracted. Pooled estimates for odds ratios (OR) were computed according ... Cited by 110 - Related articles - BL Direct - All 4 versions
VL Serebruany, AI Malinin, DL Bhatt - The American Journal of Medicine, 2006 - Elsevier Several reliable reports strongly indicate that the use of nonsteroidal
anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 (COX-2) inhibitors is
associated with an increased risk of cardiovascular events. Considering the ... Cited by 11 - Related articles - All 10 versions
L Molero, A López-Farré, PJ Mateos-Cáceres … - British journal of pharmacology, 2005 - pubmedcentral.nih.gov Inflammation and platelet activation are critical phenomena in the setting of
acute coronary syndromes. Platelets may contribute to increase ischemic injury
by enhancing the inflammatory response of leukocytes and endothelial ... Cited by 34 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org T Geisler, N Anders, M Paterok, H Langer, K … - Diabetes Care, 2007 - Am Diabetes Assoc Type 2 diabetes is accompanied by platelet function disorders leading to an
accelerated process of atherosclerosis and increased risk for atherothrombotic
complications (1–4). Previous data (5,6) suggest a worse outcome for ... Cited by 26 - Related articles - BL Direct - All 9 versions
V Evangelista, S Manarini, G Dell Elba, N … - THROMBOSIS AND HAEMOSTASIS-STUTTGART-, 2005 - mc.uky.edu Summary Clopidogrel is considered to be an important therapeutic ad- vance in
anti-platelet therapy.We investigated whether inhibition by clopidogrel results
in a reduced capacity of platelets to ad- here and stimulate pro- ... Cited by 29 - Related articles - BL Direct - All 5 versions
- ►onlinejacc.org DJ Angiolillo, E Bernardo, C Ramírez, MA … - Journal of the American College of Cardiology, 2006 - Elsevier Insulin inhibits platelet aggregation by suppressing the P2Y 12 pathway.
However, T2DM patients have a loss of responsiveness to insulin that leads to
upregulation of the P2Y 12 pathway, increased platelet reactivity, and ... Cited by 79 - Related articles - BL Direct - All 23 versions
VL Serebruany, MG Midei, H Meilman, AI … - International journal of clinical practice, 2006 - interscience.wiley.com Therapy with aspirin and/or adenosine diphosphate (ADP) receptor blockers is
associated with better outcomes via inhibition of platelet activity, and
subsequent reduction of ischemic vascular events. Non-compliance (NC) is a ... Cited by 17 - Related articles - BL Direct - All 6 versions
